HEART FAILURE NYHA CLASS III
Clinical trials for HEART FAILURE NYHA CLASS III explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS III trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a neck implant be the lifeline heart failure patients need?
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves in the neck to help the heart work better. It involves 2,500 adults with moderate heart failure who still have symptoms despite standard treatments. The goal is to see if the device reduces deaths and hospital stays…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
New implant lets heart patients check pressure from home
Disease control OngoingThis study tests a small sensor implanted in the lung artery that sends daily pressure readings to doctors. It involves 81 adults with advanced heart failure (NYHA Class III). The goal is to see if the device is safe and accurate, helping patients avoid hospital stays by catching…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Tiny lung sensor could keep heart failure patients out of the hospital
Disease control OngoingThis study tested a small sensor placed in the lung artery to help doctors monitor heart failure patients remotely. 738 people with advanced (NYHA Class III) heart failure took part. The goal was to see if using the sensor could reduce hospitalizations and deaths compared to a ta…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy injection aims to repair failing hearts
Disease control OngoingThis study tests a one-time gene therapy called AB-1002, given directly into the heart arteries, for people with advanced heart failure (NYHA Class III). The goal is to see if it can improve heart function, reduce symptoms, and lower the risk of death or hospitalization. About 15…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
No-implant heart procedure aims to help failing hearts
Symptom relief OngoingThis early study tests a device that creates a small, temporary opening in the wall of the heart to relieve pressure and improve symptoms in people with advanced heart failure. The main goal is to see if the procedure is safe. About 20 participants who have not responded well to …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: InterShunt Technologies, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure study unlocks metabolic secrets of common drug
Knowledge-focused OngoingThis study looks at how SGLT2 inhibitors, a type of diabetes drug also used for heart failure, affect the body's metabolism. About 40 adults with mild to moderate heart failure will have blood tests, walking tests, and calf MRIs before and after starting the medication. The goal …
Matched conditions: HEART FAILURE NYHA CLASS III
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC